Ayano Christine Kohlgruber, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Adipose Tissue | 7 | 2024 | 3313 | 1.030 |
Why?
|
Natural Killer T-Cells | 3 | 2020 | 322 | 0.680 |
Why?
|
Interleukin-17 | 3 | 2024 | 912 | 0.580 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 4 | 2024 | 347 | 0.530 |
Why?
|
Thermogenesis | 1 | 2018 | 475 | 0.440 |
Why?
|
Homeostasis | 4 | 2024 | 3323 | 0.420 |
Why?
|
Immunomodulation | 1 | 2016 | 549 | 0.410 |
Why?
|
Antigen Presentation | 1 | 2016 | 1251 | 0.360 |
Why?
|
Immunity | 1 | 2016 | 996 | 0.360 |
Why?
|
Energy Metabolism | 2 | 2021 | 2882 | 0.330 |
Why?
|
Dendritic Cells | 1 | 2020 | 2747 | 0.330 |
Why?
|
Diabetes Complications | 1 | 2015 | 1315 | 0.310 |
Why?
|
Receptors, Antigen, T-Cell | 2 | 2023 | 2547 | 0.310 |
Why?
|
T-Lymphocytes, Regulatory | 2 | 2018 | 3080 | 0.290 |
Why?
|
T-Lymphocyte Subsets | 3 | 2021 | 1802 | 0.280 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2020 | 4580 | 0.280 |
Why?
|
3-Iodobenzylguanidine | 2 | 2017 | 114 | 0.260 |
Why?
|
Lymphocyte Activation | 1 | 2016 | 5485 | 0.250 |
Why?
|
Lipogenesis | 1 | 2024 | 214 | 0.210 |
Why?
|
Biotinylation | 1 | 2020 | 184 | 0.180 |
Why?
|
Epitopes, T-Lymphocyte | 1 | 2023 | 828 | 0.170 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2023 | 4369 | 0.170 |
Why?
|
Neuroblastoma | 2 | 2017 | 1250 | 0.160 |
Why?
|
Interferon-gamma | 3 | 2024 | 3162 | 0.150 |
Why?
|
Melanoma, Experimental | 1 | 2021 | 561 | 0.140 |
Why?
|
Thymus Gland | 1 | 2021 | 1243 | 0.130 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2021 | 1092 | 0.120 |
Why?
|
Interleukin-10 | 1 | 2020 | 1175 | 0.120 |
Why?
|
Circadian Rhythm | 1 | 2024 | 2576 | 0.110 |
Why?
|
Animals | 11 | 2024 | 168475 | 0.110 |
Why?
|
Antigens, Neoplasm | 1 | 2020 | 1993 | 0.100 |
Why?
|
Cadherins | 1 | 2017 | 903 | 0.100 |
Why?
|
Mice, Inbred C57BL | 6 | 2024 | 22174 | 0.100 |
Why?
|
Metabolic Networks and Pathways | 1 | 2016 | 789 | 0.100 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2015 | 12149 | 0.090 |
Why?
|
Immune System | 1 | 2016 | 796 | 0.090 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2017 | 1119 | 0.090 |
Why?
|
Radiometry | 1 | 2016 | 813 | 0.090 |
Why?
|
Dendrimers | 1 | 2011 | 72 | 0.090 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2015 | 842 | 0.090 |
Why?
|
Esters | 1 | 2011 | 211 | 0.090 |
Why?
|
Disease Susceptibility | 1 | 2016 | 1787 | 0.080 |
Why?
|
Mice | 7 | 2024 | 81539 | 0.080 |
Why?
|
Colonic Neoplasms | 1 | 2021 | 2539 | 0.080 |
Why?
|
Mice, Knockout | 3 | 2020 | 14417 | 0.080 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2015 | 1651 | 0.080 |
Why?
|
Amides | 1 | 2011 | 449 | 0.080 |
Why?
|
Tumor Microenvironment | 1 | 2021 | 3878 | 0.070 |
Why?
|
Radiopharmaceuticals | 1 | 2017 | 2650 | 0.070 |
Why?
|
Inflammation | 2 | 2017 | 10774 | 0.070 |
Why?
|
Macrophages | 2 | 2018 | 5767 | 0.070 |
Why?
|
Immunity, Innate | 1 | 2018 | 3066 | 0.070 |
Why?
|
Gadolinium | 1 | 2011 | 960 | 0.060 |
Why?
|
Pyridones | 1 | 2011 | 809 | 0.060 |
Why?
|
Receptors, Interleukin-17 | 1 | 2024 | 82 | 0.060 |
Why?
|
ARNTL Transcription Factors | 1 | 2024 | 96 | 0.060 |
Why?
|
Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2024 | 152 | 0.060 |
Why?
|
Obesity | 4 | 2021 | 12947 | 0.050 |
Why?
|
Biological Clocks | 1 | 2024 | 318 | 0.050 |
Why?
|
B-Lymphocytes | 1 | 2015 | 4758 | 0.050 |
Why?
|
Membrane Proteins | 2 | 2017 | 7859 | 0.050 |
Why?
|
Body Temperature | 1 | 2024 | 781 | 0.050 |
Why?
|
Antigen-Presenting Cells | 1 | 2023 | 964 | 0.040 |
Why?
|
Organ Culture Techniques | 1 | 2021 | 795 | 0.040 |
Why?
|
HLA Antigens | 1 | 2023 | 1328 | 0.040 |
Why?
|
T-Lymphocytes | 1 | 2015 | 10194 | 0.040 |
Why?
|
Contrast Media | 1 | 2011 | 5307 | 0.040 |
Why?
|
Signal Transduction | 2 | 2021 | 23447 | 0.040 |
Why?
|
Humans | 10 | 2023 | 761596 | 0.040 |
Why?
|
Glycolysis | 1 | 2021 | 835 | 0.030 |
Why?
|
Mice, Transgenic | 2 | 2021 | 9542 | 0.030 |
Why?
|
Mice, Obese | 1 | 2017 | 420 | 0.030 |
Why?
|
Crosses, Genetic | 1 | 2017 | 750 | 0.030 |
Why?
|
Bone Morphogenetic Protein Receptors | 1 | 2015 | 46 | 0.030 |
Why?
|
Whole-Body Irradiation | 1 | 2016 | 433 | 0.030 |
Why?
|
Radiation-Sensitizing Agents | 1 | 2017 | 350 | 0.030 |
Why?
|
Interleukin-13 | 1 | 2017 | 392 | 0.030 |
Why?
|
Tumor Burden | 1 | 2021 | 1892 | 0.030 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 2016 | 882 | 0.030 |
Why?
|
Osteolysis | 1 | 2015 | 275 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2021 | 21019 | 0.030 |
Why?
|
Glucose Intolerance | 1 | 2017 | 575 | 0.030 |
Why?
|
Th2 Cells | 1 | 2018 | 1060 | 0.030 |
Why?
|
Prostatic Neoplasms | 1 | 2015 | 11122 | 0.030 |
Why?
|
Lipid Metabolism | 1 | 2021 | 1902 | 0.030 |
Why?
|
Neutropenia | 1 | 2017 | 885 | 0.020 |
Why?
|
Cell Lineage | 1 | 2021 | 2557 | 0.020 |
Why?
|
Cell Line, Tumor | 2 | 2021 | 16990 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2015 | 2016 | 0.020 |
Why?
|
Coculture Techniques | 1 | 2015 | 1341 | 0.020 |
Why?
|
Phenotype | 2 | 2021 | 16592 | 0.020 |
Why?
|
Immunotherapy, Adoptive | 1 | 2021 | 1469 | 0.020 |
Why?
|
Genome, Human | 1 | 2023 | 4425 | 0.020 |
Why?
|
Adipocytes | 1 | 2017 | 1194 | 0.020 |
Why?
|
Male | 5 | 2024 | 360846 | 0.020 |
Why?
|
Osteoblasts | 1 | 2015 | 1143 | 0.020 |
Why?
|
Stereoisomerism | 1 | 2011 | 614 | 0.020 |
Why?
|
Cell Line | 1 | 2023 | 15601 | 0.020 |
Why?
|
Genetic Markers | 1 | 2015 | 2601 | 0.020 |
Why?
|
Glucose | 1 | 2021 | 4347 | 0.020 |
Why?
|
Mitochondria | 1 | 2021 | 3624 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2015 | 3597 | 0.020 |
Why?
|
Fibroblasts | 1 | 2017 | 4142 | 0.020 |
Why?
|
Molecular Structure | 1 | 2011 | 1880 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2015 | 2898 | 0.020 |
Why?
|
Child, Preschool | 2 | 2017 | 42232 | 0.010 |
Why?
|
Ligands | 1 | 2011 | 3272 | 0.010 |
Why?
|
Pilot Projects | 1 | 2017 | 8633 | 0.010 |
Why?
|
Cytokines | 1 | 2018 | 7396 | 0.010 |
Why?
|
Insulin Resistance | 1 | 2017 | 3964 | 0.010 |
Why?
|
Bone Neoplasms | 1 | 2015 | 2529 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2016 | 12794 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2017 | 11530 | 0.010 |
Why?
|
Child | 2 | 2017 | 80158 | 0.010 |
Why?
|
Adolescent | 2 | 2017 | 88326 | 0.010 |
Why?
|
Female | 3 | 2021 | 392705 | 0.010 |
Why?
|
Time Factors | 1 | 2016 | 39969 | 0.010 |
Why?
|
Prospective Studies | 1 | 2017 | 54423 | 0.010 |
Why?
|
Adult | 2 | 2017 | 221210 | 0.010 |
Why?
|
Young Adult | 1 | 2016 | 59260 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2011 | 36426 | 0.000 |
Why?
|